Astragalin Inhibits Nuclear Factor- κB Signaling in Human Colonic Epithelial Cells and Attenuates Experimental Colitis in Mice.
Conclusions: Astragalin exerted an anti-inflammatory effect through NF-κB pathway inhibition and attenuated murine colitis. Astragalin is thus a potential therapeutic agent for IBD.
PMID: 32390406 [PubMed - as supplied by publisher]
Source: Gut and Liver - Category: Gastroenterology Tags: Gut Liver Source Type: research
More News: Flavonoids | Gastroenterology | Inflammatory Bowel Disease | Liver | Sodium | Study | Urology & Nephrology